SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001354488-15-003862
Filing Date
2015-08-14
Accepted
2015-08-14 13:21:05
Documents
10
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT tnib_10q.htm 10-Q 920919
2 CERTIFICATION tnib_ex311.htm EX-31.1 16599
3 CERTIFICATION tnib_ex312.htm EX-31.2 16265
4 CERTIFICATION tnib_ex321.htm EX-32 10771
  Complete submission text file 0001354488-15-003862.txt   2759636

Data Files

Seq Description Document Type Size
5 tnib-20150630.xml EX-101.INS 368421
6 tnib-20150630.xsd EX-101.SCH 37167
7 tnib-20150630_cal.xml EX-101.CAL 35987
8 tnib-20150630_def.xml EX-101.DEF 40620
9 tnib-20150630_lab.xml EX-101.LAB 210263
10 tnib-20150630_pre.xml EX-101.PRE 133528
Mailing Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801
Business Address 37 NORTH ORANGE AVENUE SUITE 607 ORLANDO FL 32801 (888) 613-8802
Immune Therapeutics, Inc. (Filer) CIK: 0001559356 (see all company filings)

IRS No.: 593226705 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-54933 | Film No.: 151054415
SIC: 2834 Pharmaceutical Preparations